GlassScriptPhysician profile
Daniel F Verna
NPI 1811345978
$11,965.02
in general payments reported to CMS, 2019-2025
17 companies · $1,135 in 2025
The $1,135 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $34.34 · 2021: $335 · 2022: $52.55 · 2023: $91.50 · 2024: $10K · 2025: $1,135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Travel and Lodging: $2,390 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Travel and Lodging | $2,390.29 |
| Food and Beverage | $1,005.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,088.31 | 2024 | |
| Davol INC. | $938.62 | 2025 | Phasix Mesh |
| Stryker Corporation | $353.33 | 2020-2021 | |
| Acell, INC. | $124.16 | 2019 | |
| Smith+Nephew, INC. | $105.63 | 2024-2025 | Collagenase Santyl, Grafix, Oasis |
| Integra Lifesciences Corporation | $68.71 | 2021-2022 | |
| Organogenesis INC. | $45.63 | 2023-2024 | Puraply |
| Aroa Biosurgery Incorporated | $42.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $33.23 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $28.45 | 2023 | Seglentis |
| Solventum Corporation | $24.59 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ethicon US, LLC | $23.15 | 2019 | |
| Medtronic, INC. | $20.90 | 2023 | Valiant Captivia |
| Innovation Technologies INC | $19.69 | 2025 | Irrisept |
| Kci USA, INC. | $18.96 | 2023 | Prevena, Abthera, V.A.C. Veraflo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuros Medical, INC. | $18.22 | 2025 | Altius |
| Kerecis Limited | $11.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Verna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.